Ihsan Qamar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Ihsan Qamar has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Abarna Nayyar
Department of Medicine, Rashid Latif Medical College, Lahore, Pakistan
1 shared publication Abdul Aleem
Department of Medicine, Shaheed Monsur Ali Medical College & Hospitals, Dhaka University, Dhaka, Bangladesh
1 shared publication- Abdullah Imtiaz
Department of Medicine, Wah Medical College, National University of Medical Sciences (NUMS), Wah Cantt, Rawalpindi, Pakistan
1 shared publication - Alaa Abdel-Akher
Department of Medicine, NewGiza University, Cairo, Egypt
1 shared publication Aleena Amir Malik
United Medical and Dental College, Karachi, Pakistan
1 shared publication- Aleeza Abid
Jinnah Sindh Medical University
1 shared publication
Latest Publications
- Open Access
- 14 November 2026
- Published by Springer Nature in Scientific Reports
Trends in deaths involving melanoma and cardiovascular disease among older US adults from 1999 to 2020
- 14 November 2026
- Published by Springer Nature in Scientific Reports
Open AccessTrends in deaths involving melanoma and cardiovascular disease among older US adults from 1999 to 2020
- Open Access
- 5 November 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
Advancing the treatment of hypertriglyceridemia: a systematic review and meta-analysis of olezarsen
- 5 November 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
Open AccessAdvancing the treatment of hypertriglyceridemia: a systematic review and meta-analysis of olezarsen
- Open Access
- 16 October 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (42) , e51123
Knowledge, attitude, and acceptance of euthanasia among medical students and doctors in Pakistan
Globally, euthanasia is a strongly debated and ethically complex issue, with views shaped by cultural, religious, and moral precepts. In conservative cultures like Pakistan, euthanasia discussions are sensitive and occasionally ignored. This study aims to evaluate medical professionals’ and students’ knowledge, attitudes, and acceptance of euthanasia in Pakistan. From May 16 to June 16, 2025, a cross-sectional survey was conducted involving 10 Pakistani medical institutions. The study utilized convenience sampling to select MBBS first- and final-year students and practicing doctors with a minimum of 1 year of clinical experience. Outcomes were assessed using a modified Attitudes Toward Euthanasia scale and structured knowledge items to evaluate knowledge of euthanasia, attitudes toward it, and the acceptability of its legalization. Descriptive statistics summarized participant characteristics, while one-way analysis of variance and independent-samples t tests were used to assess differences in mean attitude ratings across demographic categories. Chi-square tests analyzed relationships between categorical factors and euthanasia approval, and Spearman rank correlation examined connections between attitude ratings and continuous variables such as age and clinical experience. Statistical significance was set at P < .05. A study involving 506 participants, including first-year and final-year medical students and practicing physicians, found that only 40.1% favored euthanasia. Knowledge and attitude scores averaged 66.4 ± 10.8 and 8.7 ± 2.1, respectively, with a positive correlation between them (ρ = 0.44, P < .01). Practicing physicians showed significantly higher acceptance than students, particularly those with lower religiosity ( P < .05). Acceptance of euthanasia is related significantly to religion and religiosity, with non-Muslims and less religious participants more likely to accept it. Gender, occupation, religion, province, and religiosity were independent predictors of attitude scores, while religion and religiosity were the strongest predictors of approval in logistic regression. Pakistani medical students and doctors possess limited knowledge and varied attitudes toward euthanasia, significantly influenced by professional experience, level of training, and religious beliefs. Misconceptions about the legal and ethical aspects emphasize the need for integrating structured bioethics and end-of-life care education in medical training. Targeted educational initiatives can enhance ethically informed decision-making among healthcare professionals.
- 16 October 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (42) , e51123
Open AccessKnowledge, attitude, and acceptance of euthanasia among medical students and doctors in Pakistan
Globally, euthanasia is a strongly debated and ethically complex issue, with views shaped by cultural, religious, and moral precepts. In conservative cultures like Pakistan, euthanasia discussions are sensitive and occasionally ignored. This study aims to evaluate medical professionals’ and students’ knowledge, attitudes, and acceptance of euthanasia in Pakistan. From May 16 to June 16, 2025, a cross-sectional survey was conducted involving 10 Pakistani medical institutions. The study utilized convenience sampling to select MBBS first- and final-year students and practicing doctors with a minimum of 1 year of clinical experience. Outcomes were assessed using a modified Attitudes Toward Euthanasia scale and structured knowledge items to evaluate knowledge of euthanasia, attitudes toward it, and the acceptability of its legalization. Descriptive statistics summarized participant characteristics, while one-way analysis of variance and independent-samples t tests were used to assess differences in mean attitude ratings across demographic categories. Chi-square tests analyzed relationships between categorical factors and euthanasia approval, and Spearman rank correlation examined connections between attitude ratings and continuous variables such as age and clinical experience. Statistical significance was set at P < .05. A study involving 506 participants, including first-year and final-year medical students and practicing physicians, found that only 40.1% favored euthanasia. Knowledge and attitude scores averaged 66.4 ± 10.8 and 8.7 ± 2.1, respectively, with a positive correlation between them (ρ = 0.44, P < .01). Practicing physicians showed significantly higher acceptance than students, particularly those with lower religiosity ( P < .05). Acceptance of euthanasia is related significantly to religion and religiosity, with non-Muslims and less religious participants more likely to accept it. Gender, occupation, religion, province, and religiosity were independent predictors of attitude scores, while religion and religiosity were the strongest predictors of approval in logistic regression. Pakistani medical students and doctors possess limited knowledge and varied attitudes toward euthanasia, significantly influenced by professional experience, level of training, and religious beliefs. Misconceptions about the legal and ethical aspects emphasize the need for integrating structured bioethics and end-of-life care education in medical training. Targeted educational initiatives can enhance ethically informed decision-making among healthcare professionals.
- Open Access
- 9 June 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (7) , 4718-4719
CRISPR-based epigenetic modulation of endothelial dysfunction in sepsis-induced ARDS: a precision medicine framework
Was not provided for this article.
- 9 June 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (7) , 4718-4719
Open AccessCRISPR-based epigenetic modulation of endothelial dysfunction in sepsis-induced ARDS: a precision medicine framework
Was not provided for this article.
- Open Access
- 14 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3404-3410
Zoliflodacin for uncomplicated gonorrhea: clinical evidence and implications beyond ceftriaxone plus azithromycin
Background: Globally, gonorrhea remains a common sexually transmitted infection that can lead to serious sexual and reproductive health complications if left untreated. Management has become more challenging due to the rapid progression of antimicrobial resistance in Neisseria gonorrhoeae . Currently, ceftriaxone-based regimens continue to be the standard treatment; however, the sudden demand for new treatment options is highlighted by concerns regarding resistance, the requirement for intramuscular administration, and the declining effectiveness of azithromycin. Objective: This review aims to evaluate the emerging role of zoliflodacin in the treatment of gonorrhea, with an emphasis on its potential to serve as a resistance-focused alternative, its oral administration, and its novel antimicrobial target. Methods: A narrative literature search was conducted using PubMed, Google Scholar, and Scopus to identify relevant studies published between 2016 and 2026. Randomized clinical trials, systematic reviews, narrative reviews, and international guidelines from the WHO, ECDC, and CDC were included. Literature selection was guided by SANRA. Results: A single 3-g oral dose of zoliflodacin appears to exhibit high microbiological cure rates for uncomplicated urogenital and rectal gonorrhea, and it is not less effective than ceftriaxone plus azithromycin for urogenital infections, according to Phase 2 and recent global Phase 3 clinical trials, which reported mild gastrointestinal side effects. Its mechanism of action provides limited evidence of resistance and is effective against multidrug-resistant Neisseria gonorrhoeae . Conclusion: Zoliflodacin represents a potentially effective oral alternative to the current ceftriaxone-based regimen for gonorrhea. With routine observation and careful stewardship, these findings may contribute significantly to the expansion of future treatment strategies.
- 14 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3404-3410
Open AccessZoliflodacin for uncomplicated gonorrhea: clinical evidence and implications beyond ceftriaxone plus azithromycin
Background: Globally, gonorrhea remains a common sexually transmitted infection that can lead to serious sexual and reproductive health complications if left untreated. Management has become more challenging due to the rapid progression of antimicrobial resistance in Neisseria gonorrhoeae . Currently, ceftriaxone-based regimens continue to be the standard treatment; however, the sudden demand for new treatment options is highlighted by concerns regarding resistance, the requirement for intramuscular administration, and the declining effectiveness of azithromycin. Objective: This review aims to evaluate the emerging role of zoliflodacin in the treatment of gonorrhea, with an emphasis on its potential to serve as a resistance-focused alternative, its oral administration, and its novel antimicrobial target. Methods: A narrative literature search was conducted using PubMed, Google Scholar, and Scopus to identify relevant studies published between 2016 and 2026. Randomized clinical trials, systematic reviews, narrative reviews, and international guidelines from the WHO, ECDC, and CDC were included. Literature selection was guided by SANRA. Results: A single 3-g oral dose of zoliflodacin appears to exhibit high microbiological cure rates for uncomplicated urogenital and rectal gonorrhea, and it is not less effective than ceftriaxone plus azithromycin for urogenital infections, according to Phase 2 and recent global Phase 3 clinical trials, which reported mild gastrointestinal side effects. Its mechanism of action provides limited evidence of resistance and is effective against multidrug-resistant Neisseria gonorrhoeae . Conclusion: Zoliflodacin represents a potentially effective oral alternative to the current ceftriaxone-based regimen for gonorrhea. With routine observation and careful stewardship, these findings may contribute significantly to the expansion of future treatment strategies.
- Open Access
- 1 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3895-3896
Coronary pericytes as mediators of brain–gut–heart signaling: expanding the cardioprotective paradigm of GLP-1
- 1 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3895-3896
Open AccessCoronary pericytes as mediators of brain–gut–heart signaling: expanding the cardioprotective paradigm of GLP-1